Delivery Order SPE2DE21D0005-SPE2D625F52FT

Award Date 1/30/25
Potential Completion Date 2/4/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The contract, valued at $1,239.95, is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical and the Department of Veterans Affairs (VA) for the supply of APLIGRAF, a skin substitute product. The contract has not utilized any set-aside designation, indicating Organogenesis competes as a standard commercial vendor. Organogenesis holds several...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The contract is a delivery order for APLIGRAF, a skin substitute product. The contract has no set-aside designation, indicating Organogenesis competed as a standard commercial vendor. Organogenesis is a key supplier of advanced wound care, surgical biologics, and tissue regeneration products to federal healthcare...
This federal contract award, with ID SPE2DE21D0005|SPE2D625F31DY, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products headquartered in Canton, Massachusetts. The $1,239.95 delivery order is for the supply of APLIGRAF, a skin substitute product, and does not utilize any set-aside designation. Organogenesis is an established vendor for the DLA and the Department of Veterans Affairs (VA), providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading manufacturer of regenerative medicine products. The order, valued at $1,239.95, is for the company's APLIGRAF skin substitute product. The order is a fixed-price contract with economic price adjustment, and does not utilize a set-aside designation. Organogenesis Inc. is a long-standing federal contractor, providing a range of wound care and surgical biologics to the...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
This federal contract award is to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The contract, valued at $2,479.90, is a delivery order issued under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The award is for the supply of the APLIGRAF advanced wound care product, a specialized skin substitute and tissue regeneration solution used in medical treatments. The contract does not utilize any set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support to Organogenesis Inc., a for-profit manufacturer of advanced regenerative medicine products. The $1,239.95 fixed-price contract is for the supply of the APLIGRAF wound care product, with a period of performance through November 1, 2024. Organogenesis is an established federal contractor, holding several significant Indefinite Delivery Vehicles (IDVs) with the Department of...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract is a delivery order for the company's APLIGRAF product, a skin substitute used in advanced wound care. The award is part of a larger $183.15 million multiple-award Indefinite Delivery Contract (IDC) the DLA awarded to Organogenesis and other suppliers for medical and surgical supplies under the...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F52FT
    Delivery Order

This federal contract award is for a delivery order (SPE2DE21D0005|SPE2D625F52FT) with a ceiling value of $1,239.95, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Organogenesis Inc., a for-profit medical manufacturer headquartered in Canton, Massachusetts. The contract is for the supply of APLIGRAF, a skin substitute product, to support wound care and tissue regeneration needs across military and veteran healthcare systems.

Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, including a $25 million single-award IDC for surgical implants, a $30 million multiple-award Federal Supply Schedule contract for medical equipment and supplies, and a $49.5 million multiple-award IDC for wound care dressings. These contract vehicles enable Organogenesis to provide a comprehensive range of regenerative medicine products to the government. This particular delivery order does not utilize a set-aside designation, indicating Organogenesis competes as a standard commercial vendor.

Generated 5/1/25, 10:15 AM